GB2064
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB2064, covering 2024-04-03 to 2024-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis [Phase 2]